Fei Teng

3.7k total citations
107 papers, 2.4k citations indexed

About

Fei Teng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fei Teng has authored 107 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 28 papers in Cancer Research and 24 papers in Oncology. Recurrent topics in Fei Teng's work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (12 papers) and Circular RNAs in diseases (10 papers). Fei Teng is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (12 papers) and Circular RNAs in diseases (10 papers). Fei Teng collaborates with scholars based in China, United States and United Kingdom. Fei Teng's co-authors include Yingmei Wang, Fengxia Xue, Xiaomin Shi, Wenyan Tian, Qi Zhou, Wei Li, Yuhuan Li, Guihai Feng, Lu Guo and Ying Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Fei Teng

101 papers receiving 2.3k citations

Peers

Fei Teng
Ling Xu China
Yao Zhang China
Rohan Samarakoon United States
Jing Luo China
Ling Xu China
Fei Teng
Citations per year, relative to Fei Teng Fei Teng (= 1×) peers Ling Xu

Countries citing papers authored by Fei Teng

Since Specialization
Citations

This map shows the geographic impact of Fei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Teng more than expected).

Fields of papers citing papers by Fei Teng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Teng. The network helps show where Fei Teng may publish in the future.

Co-authorship network of co-authors of Fei Teng

This figure shows the co-authorship network connecting the top 25 collaborators of Fei Teng. A scholar is included among the top collaborators of Fei Teng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fei Teng. Fei Teng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Jiang, Haiyang, Tomislav Capuder, Fei Teng, et al.. (2024). Generation and transmission expansion planning incorporating economically feasible heterogeneous demand-side resources. Applied Energy. 381. 125067–125067. 1 indexed citations
4.
Teng, Fei, Tongtong Cui, Li Zhou, et al.. (2024). Programmable synthetic receptors: the next-generation of cell and gene therapies. Signal Transduction and Targeted Therapy. 9(1). 7–7. 26 indexed citations
5.
Zhang, Shiming, et al.. (2024). A survey of route recommendations: Methods, applications, and opportunities. Information Fusion. 108. 102413–102413. 8 indexed citations
6.
Zhang, Xiaohan, Mansheng Li, Nana Zhang, et al.. (2024). SARS‐CoV‐2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations. Advanced Science. 11(40). e2402639–e2402639. 4 indexed citations
8.
He, Chao, Yongfeng Ding, Yan Yang, et al.. (2023). Stem cell landscape aids in tumor microenvironment identification and selection of therapeutic agents in gastric cancer. Cellular Signalling. 113. 110965–110965. 3 indexed citations
10.
Yang, Pinghua, Fei Teng, Yong Xia, et al.. (2022). Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks. Gastroenterology report. 11. goad035–goad035. 5 indexed citations
11.
Bian, Rongrong, et al.. (2022). The pharmacokinetic study of tacrolimus and Wuzhi capsule in Chinese liver transplant patients. Frontiers in Pharmacology. 13. 956166–956166. 4 indexed citations
12.
Li, Zhijun, Nan Jia, Wei Cui, et al.. (2021). Epidemiological and clinical findings of discharge patients infected with the 2019 novel coronavirus (SARS-COV-2) in Changchun, Northeast China: A retrospective cohort study. 37(2). 1147–1153. 2 indexed citations
13.
Mao, Jia-Xi, et al.. (2020). Pooled analysis of hepatic inflammatory angiomyolipoma. Clinics and Research in Hepatology and Gastroenterology. 44(6). e145–e151. 6 indexed citations
15.
Song, Shaohua, Fei Teng, Hao Liu, et al.. (2019). Protective effect of salvianolate against bile duct injury after DCD donor liver transplantation. SHILAP Revista de lepidopterología. 44(2). 132–136. 1 indexed citations
16.
Mao, Jia-Xi, et al.. (2018). 409 patients with hepatic epithelioid angiomyolipoma: A pooled analysis. Zhonghua gan-dan waike zazhi. 24(10). 659–663. 2 indexed citations
17.
Mao, Jia-Xi, Hang Yuan, Fei Teng, et al.. (2018). A single-center experience of liver transplantation for alcoholic liver disease. Zhonghua gan-dan waike zazhi. 24(3). 150–154. 1 indexed citations
18.
Feng, Liang, Hong Jiang, Yunxia Li, Fei Teng, & Yusheng He. (2017). Effects of citicoline therapy on the network connectivity of the corpus callosum in patients with leukoaraiosis. Medicine. 96(4). e5931–e5931. 5 indexed citations
19.
Teng, Fei, et al.. (2017). Life-threatening hemorrhage from the corona mortis treated with balloon-assisted coiling technique. The American Journal of Emergency Medicine. 36(3). 527.e1–527.e3. 4 indexed citations
20.
Liang, Jun, Yanping Li, Na Zhou, et al.. (2012). Synergistic Effects of Serum Uric Acid and Cardiometabolic Risk Factors on Early Stage Atherosclerosis: The Cardiometabolic Risk in Chinese Study. PLoS ONE. 7(12). e51101–e51101. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026